<b> U.S. ATryn Development Timeline for HD Indication </b> [These expectations are based on the slightly-updated guidance in today’s press release (<a href='read_msg.asp?message_id=19329705'>#msg-19329705</a>).] 3Q07: Complete enrollment 4Q07: Report clinical results Early 2008: Submit BLA Late 2008/early 2009: FDA decision on BLA